4 min read
ASCO, ACCC join forces to increase diversity in cancer clinical trials
ASCO, ACCC join forces to increase diversity in cancer clinical trials Published: May 24, 2022 By Geoff Herman BioSpace The American Society of
Tag : Clinical Trials
4 min read
2 min read
Following disappointing trial and assessment, Genocea shutters its doors
Following disappointing trial and assessment, Genocea shutters its doors Published: May 24, 2022 By Alex Keown BioSpace After announcing plans
2 min read
Inaugural patient injected with cancer-killing oncolytic virus
Inaugural patient injected with cancer-killing oncolytic virus Published: May 24, 2022 By Jazmine Colatriano M.S. BioSpace Imugene and City of
1 min read
Pfizer ulcerative colitis drug leads to remission in a third of patients – study
Pfizer ulcerative colitis drug leads to remission in a third of patients – study May 24, 2022, 6:50 AM EDT By Michael Erman (Reuters) –
2 min read
Regeneron’s Evicanumab Fights Ultra-Rare Form of High Cholesterol in Kids
Regeneron’s Evicanumab Fights Ultra-Rare Form of High Cholesterol in Kids Published: May 23, 2022 By Vanessa Doctor, RN BioSpace Regeneron
2 min read
Regeneron’s Evicanumab Fights Ultra-Rare Form of High Cholesterol in Kids
Regeneron’s Evicanumab Fights Ultra-Rare Form of High Cholesterol in Kids Published: May 23, 2022 By Vanessa Doctor, RN BioSpace Regeneron
1 min read
Biohaven’s drug for neurological disease fails late-stage study
Biohaven’s drug for neurological disease fails late-stage study May 23, 2022; 8:55 AM EDT (Reuters) – Biohaven Pharmaceutical (BHVN.N) said on
1 min read
Biohaven’s drug for neurological disease fails late-stage study
Biohaven’s drug for neurological disease fails late-stage study May 23, 2022; 8:55 AM EDT (Reuters) – Biohaven Pharmaceutical (BHVN.N) said on
2 min read
Pfizer/BioNTech say 3 COVID shots elicit good response in children under 5
Pfizer/BioNTech say 3 COVID shots elicit good response in children under 5 May 23, 2022, 10:49 AM EDT By Michael Erman (Reuters) – Drugmakers
2 min read
Pfizer/BioNTech say 3 COVID shots elicit good response in children under 5
Pfizer/BioNTech say 3 COVID shots elicit good response in children under 5 May 23, 2022, 10:49 AM EDT By Michael Erman (Reuters) – Drugmakers
1 min read
U.S. drug regulator lifts clinical hold on Ocugen’s COVID vaccine trial
U.S. drug regulator lifts clinical hold on Ocugen’s COVID vaccine trial May 23, 2022, 7:33 AM EDT (Reuters) – Ocugen Inc (OCGN.O) said on Monday
AbbVie Submits New Drug Application to U.S. FDA for Investigational ABBV-951 (Foscarbidopa/Foslevodopa) for the Treatment of Advanced Parkinson’s Disease
AbbVie Submits New Drug Application to U.S. FDA for Investigational ABBV-951 (Foscarbidopa/Foslevodopa) for the Treatment of Advanced Parkinson’s
2 min read
Following patient death, FDA puts Foghorn study on partial hold
Following patient death, FDA puts Foghorn study on partial hold Published: May 20, 2022 By Jazmine Colatriano, M.S. BioSpace The U.S. Food and Drug
2 min read
Report: Pfizer, NIH Discussing Study of Longer Paxlovid Dosing Regimen
Report: Pfizer, NIH Discussing Study of Longer Paxlovid Dosing Regimen Published: May 18, 2022 By Alex Keown BioSpace With increasing concerns
3 min read
Why Pfizer May Be Holding Paxlovid Close to the Chest
Why Pfizer May Be Holding Paxlovid Close to the Chest Published: May 18, 2022 By Mark Terry BioSpace Reportedly, Pfizer is holding its